BioSyent Cash Flow | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | BioSyent Inc.

BioSyent Inc. | Cash Flow

Fiscal year is January-December. All values CAD Thousands.

2013

2014

2015

2016

2017

2018

Net Income before Extraordinaries

1,928.00

3,154.10

3,764.90

4,309.50

5,206.30

5,705.40

Depreciation, Depletion & Amortization

34.90

45.60

61.40

146.60

189.60

185.30

Other Funds

383.30

18.80

184.10

86.70

58.40

744.90

Funds from Operations

2,346.20

3,285.50

4,140.50

4,588.70

5,658.00

6,729.80

Changes in Working Capital

193.90

354.50

1,329.50

189.60

888.10

443.20

Net Operating Cash Flow

2,152.20

3,640.00

2,810.90

4,399.00

6,546.10

6,286.60

Capital Expenditures

131.00

75.20

1,147.50

405.50

640.50

Purchase/Sale of Investments

1,000.00

4,322.90

4,639.70

6,003.30

Net Investing Cash Flow

131.00

1,075.20

5,470.40

4,234.20

7,037.60

Net Financing Cash Flow

34.80

34.30

18.70

63.60

110.90

Net Change in Cash

2,065.10

2,608.00

2,596.60

8,663.50

404.10

Free Cash Flow

2,074.30

3,578.60

2,682.10

4,257.00

6,455.00

Deferred Taxes & Investment Tax Credit

104.70

130.10

45.80

203.80

94.20

Change in Capital Stock

34.80

34.30

18.70

63.60

110.90

Exchange Rate Effect

9.00

8.90

44.20

33.30

23.50

Other Uses

393.90

About BioSyent

View Profile

Address	170 Attwell Drive Toronto Ontario M9W 5Z5 Canada
Employees	-
Website	http://www.biosyent.com
Updated	07/08/2019
BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System, and Cysview. The company was founded on April 28, 1947 and is headquartered in Ontario, Canada.